|
1
|
Yao DF and Dong ZZ: Hepatocellular-related
gamma-glutamyl transferase in laboratory or clinical diagnosis of
hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 6:9–11.
2007.PubMed/NCBI
|
|
2
|
Gao J, Chen M and Ren H: [Clinical effects
of dendritic cells pulsed with autologous hepatocellular cell
lysates on the postoperative recurrence and metastasis of
hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi.
13:432–435. 2005.(In Chinese). PubMed/NCBI
|
|
3
|
Wang S and Fang W: Increased expression of
hepatocellular-derived growth factor correlates with poor prognosis
in human nasopharyngeal carcinoma. Histopathology. 58:217–224.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Filipowicz W: RNAi: The nuts and bolts of
the RISC machine. Cell. 122:17–20. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: microRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mishra PJ and Merlino G: MicroRNA
reexpression as differentiation therapy in cancer. J Clin Invest.
119:2119–2123. 2009.PubMed/NCBI
|
|
9
|
Ryan BM, Robles AI and Harris CC: Genetic
variation in microRNA networks: The implications for cancer
research. Nat Rev Cancer. 10:389–402. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
94:776–780. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu R, Zeng G, Gao J, Ren Y, Zhang Z, Zhang
Q, Zhao J, Tao H and Li D: miR-138 suppresses the proliferation of
oral squamous cell carcinoma cells by targeting Yes-associated
protein 1. Oncol Rep. 34:2171–2178. 2015.PubMed/NCBI
|
|
14
|
Liu X, Lv XB, Wang XP, Sang Y, Xu S, Hu K,
Wu M, Liang Y, Liu P, Tang J, et al: MiR-138 suppressed
nasopharyngeal carcinoma growth and tumorigenesis by targeting the
CCND1 oncogene. Cell Cycle. 11:2495–2506. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang H, Zhang H, Zhao M, Lv Z, Zhang X,
Qin X, Wang H, Wang S, Su J, Lv X, et al: MiR-138 inhibits tumor
growth through repression of EZH2 in non-small cell lung cancer.
Cell Physiol Biochem. 31:56–65. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ye XW, Yu H, Jin YK, Jing XT, Xu M, Wan ZF
and Zhang XY: miR-138 inhibits proliferation by targeting
3-phosphoinositide-dependent protein kinase-1 in non-small cell
lung cancer cells. Clin Respir J. 9:27–33. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang W, Zhao LJ, Tan YX, Ren H and Qi ZT:
MiR-138 induces cell cycle arrest by targeting cyclin D3 in
hepatocellular carcinoma. Carcinogenesis. 33:1113–1120. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Maiese K, Chong ZZ, Shang YC and Hou J:
Novel avenues of drug discovery and biomarkers for diabetes
mellitus. J Clin Pharmacol. 51:128–152. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Knight JR and Milner J: SIRT1, metabolism
and cancer. Curr Opin Oncol. 24:68–75. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ikeda K, Satoh M, Pauley KM, Fritzler MJ,
Reeves WH and Chan EK: Detection of the argonaute protein Ago2 and
microRNAs in the RNA induced silencing complex (RISC) using a
monoclonal antibody. J Immunol Methods. 317:38–44. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lim LP, Lau NC, Garrett-Engele P, Grimson
A, Schelter JM, Castle J, Bartel DP, Linsley PS and Johnson JM:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dalmay T and Edwards DR: MicroRNAs and the
hallmarks of cancer. Oncogene. 25:6170–6175. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gaziel-Sovran A, Segura MF, Di Micco R,
Collins MK, Hanniford D, de Vega-Saenz Miera E, Rakus JF, Dankert
JF, Shang S, Kerbel RS, et al: miR-30b/30d regulation of
GalNAc transferases enhances invasion and immunosuppression during
metastasis. Cancer Cell. 20:104–118. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang CH, Yue J, Pfeffer SR, Handorf CR and
Pfeffer LM: MicroRNA miR-21 regulates the metastatic behavior of
B16 melanoma cells. J Biol Chem. 286:39172–39178. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Oneyama C, Morii E, Okuzaki D, Takahashi
Y, Ikeda J, Wakabayashi N, Akamatsu H, Tsujimoto M, Nishida T,
Aozasa K, et al: MicroRNA-mediated upregulation of integrin-linked
kinase promotes Src-induced tumor progression. Oncogene.
31:1623–1635. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li N, Fu H, Tie Y, Hu Z, Kong W, Wu Y and
Zheng X: miR-34a inhibits migration and invasion by down-regulation
of c-Met expression in human hepatocellular carcinoma cells. Cancer
Lett. 275:44–53. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fang JH, Zhou HC, Zeng C, Yang J, Liu Y,
Huang X, Zhang JP, Guan XY and Zhuang SM: MicroRNA-29b suppresses
tumor angiogenesis, invasion, and metastasis by regulating matrix
metalloproteinase 2 expression. Hepatology. 54:1729–1740. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu Y, Zhao F, Wang Z, Song Y, Luo Y, Zhang
X, Jiang L, Sun Z, Miao Z and Xu H: MicroRNA-335 acts as a
metastasis suppressor in gastric cancer by targeting Bcl-w and
specificity protein 1. Oncogene. 31:1398–1407. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang Y, Chen HC, Chiang CW, Yeh CT, Chen
SJ and Chou CK: Identification of a two-layer regulatory network of
proliferation-related microRNAs in hepatocellular cells. Nucleic
Acids Res. 40:10478–10493. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fornari F, Milazzo M, Chieco P, Negrini M,
Calin GA, Grazi GL, Pollutri D, Croce CM, Bolondi L and Gramantieri
L: MiR-199a-3p regulates mTOR and c-Met to influence the
doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res.
70:5184–5193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hurst DR, Edmonds MD and Welch DR:
Metastamir: The field of metastasis-regulatory microRNA is
spreading. Cancer Res. 69:7495–7498. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chan JA, Krichevsky AM and Kosik KS:
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
Cancer Res. 65:6029–6033. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Asangani IA, Rasheed SA, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21)
post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang P, Zou F, Zhang X, Li H, Dulak A,
Tomko RJ Jr, Lazo JS, Wang Z, Zhang L and Yu J: microRNA-21
negatively regulates Cdc25A and cell cycle progression in colon
cancer cells. Cancer Res. 69:8157–8165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Park SM, Gaur AB, Lengyel E and Peter ME:
The miR-200 family determines the epithelial phenotype of cancer
cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes
Dev. 22:894–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Korpal M, Lee ES, Hu G and Kang Y: The
miR-200 family inhibits epithelial-mesenchymal transition and
cancer cell migration by direct targeting of E-cadherin
transcriptional repressors ZEB1 and ZEB2. J Biol
Chem. 283:14910–14914. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang FE, Zhang C, Maminishkis A, Dong L,
Zhi C, Li R, Zhao J, Majerciak V, Gaur AB, Chen S, et al:
MicroRNA-204/211 alters epithelial physiology. FASEB J.
24:1552–1571. 2010. View Article : Google Scholar : PubMed/NCBI
|
